Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 1, 2022
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
[ Wed, Jun 01st 2022
] - WOPRAI
Tue, May 31, 2022
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
[ Tue, May 31st 2022
] - WOPRAI
Ami Fadia Maintained (AVDL) at Strong Buy with Decreased Target to $6 on, May 31st, 2022
Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Decreased Target from $14 to $6 on, May 31st, 2022.
Ami has made no other calls on AVDL in the last 4 months.
There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ami
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $6 on, Friday, May 27th, 2022
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $13 on, Friday, May 27th, 2022
